Assenagon Asset Management
PRTK

Assenagon Asset Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Assenagon Asset Management’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-368,240
Closed -$935K – 1459
2023
Q1 		$935K Buy
368,240
+236,976
+181% +$602K ﹤0.01% 1032
2022
Q4 		$245K Sell
131,264
-83,141
-39% -$155K ﹤0.01% 1237
2022
Q3 		$551K Buy
214,405
+120,393
+128% +$309K ﹤0.01% 1042
2022
Q2 		$181K Buy
+94,012
New +$181K ﹤0.01% 1342